Newsroom - Tozaro

Tozaro announces formation of Technical Advisory Board to support commercialization of Smart Polymers in cell and gene therapy bioprocessing

May 13, 2025

Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing, today announced the formation of its …

Tozaro appoints Dr. Jason Slingsby MBA as CEO to lead company strategy in cell and gene therapy sector

May 1, 2025

By Keli

Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing today announced the appointment of Dr. Jason Slingsby MBA as Chief Executive Officer, effective 22 April 2025.

MIP Discovery rebrands as Tozaro as it completes transition to supporting cell and gene therapy viral vector analytics and purification

August 5, 2024

By Keli

Bedfordshire, UK, 06 August 2024: MIP Discovery today announced the Company’s rebrand to Tozaro, completing its transition to becoming a …

Tozaro closes £7M Series A financing to drive commercialization in cell and gene therapy space

February 19, 2024

By celf_admin

Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making …

Tozaro (formally MIP Discovery) secures significant funding to support development of global rapid response diagnostics

February 1, 2023

By celf_admin

Funding received from the Bill & Melinda Gates Foundation for rapid deployment of novel detection reagents to support mass scale …

Fill in the form below to complete your download